Actinium Pharmaceuticals, Inc. (ATNM)
SG&A Expense Growth
25.98%
Fiscal year · Period ending:
ATNM SG&A Expense Growth
Latest reported25.98%period ending
Latest reported25.98%period ending
ATNM FY SG&A Growth (YoY) (0.00% → 25.98%)
Latest values, visible window
High-resolution chart · PNG
ATNM sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.9771% | |
| -9.4141% | |
| 11.1009% | |
| 48.5576% | |
| 28.0438% | |
| 23.6459% | |
| -24.2289% | |
| -26.4555% | |
| -1.2299% | |
| -19.1539% | |
| 12.6781% | |
| 159.6326% | |
| -13.0271% | |
| 46,764.2746% | |
| -62.1531% | |
| 74.785% | |
| -23.1603% | |
| 71.7918% | |
| -37.202% | |
| 0% |